Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of psoas compartment block on postoperative pain and recovery after nephrectomy
2024-519910-30-00Phase 4Authorised
- Sponsor
- Pirkanmaan hyvinvointialue
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and dexamethasone in renal cell carcinoma (RCC), sponsored by Pirkanmaan hyvinvointialue. Primary endpoint: Cumulative opioid consumption. Planned start Jan 2025; status: authorised.
02
Drugs
ropivacainedexamethasone
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2024-519910-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519910-30-00.